Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
Int J Mol Sci. 2022 Apr 16;23(8):4413. doi: 10.3390/ijms23084413.
Glycogen synthase kinase 3β (GSK3) is a multifaceted serine/threonine (S/T) kinase expressed in all eukaryotic cells. GSK3β is highly enriched in neurons in the central nervous system where it acts as a central hub for intracellular signaling downstream of receptors critical for neuronal function. Unlike other kinases, GSK3β is constitutively active, and its modulation mainly involves inhibition via upstream regulatory pathways rather than increased activation. Through an intricate converging signaling system, a fine-tuned balance of active and inactive GSK3β acts as a central point for the phosphorylation of numerous primed and unprimed substrates. Although the full range of molecular targets is still unknown, recent results show that voltage-gated ion channels are among the downstream targets of GSK3β. Here, we discuss the direct and indirect mechanisms by which GSK3β phosphorylates voltage-gated Na channels (Na1.2 and Na1.6) and voltage-gated K channels (K4 and K7) and their physiological effects on intrinsic excitability, neuronal plasticity, and behavior. We also present evidence for how unbalanced GSK3β activity can lead to maladaptive plasticity that ultimately renders neuronal circuitry more vulnerable, increasing the risk for developing neuropsychiatric disorders. In conclusion, GSK3β-dependent modulation of voltage-gated ion channels may serve as an important pharmacological target for neurotherapeutic development.
糖原合酶激酶 3β(GSK3β)是一种在所有真核细胞中表达的多功能丝氨酸/苏氨酸(S/T)激酶。GSK3β在中枢神经系统中的神经元中高度富集,在那里它作为受体下游细胞内信号的中央枢纽,这些受体对神经元功能至关重要。与其他激酶不同,GSK3β是组成性激活的,其调节主要涉及通过上游调节途径抑制,而不是增加激活。通过复杂的汇聚信号系统,活性和非活性 GSK3β 的精细平衡作为众多被激活和未被激活底物磷酸化的中心点。尽管分子靶标的完整范围仍不清楚,但最近的结果表明,电压门控离子通道是 GSK3β 的下游靶标之一。在这里,我们讨论了 GSK3β 直接和间接磷酸化电压门控 Na 通道(Na1.2 和 Na1.6)和电压门控 K 通道(K4 和 K7)的机制及其对固有兴奋性、神经元可塑性和行为的生理影响。我们还提供了证据,证明不平衡的 GSK3β 活性如何导致适应性不良的可塑性,最终使神经元回路更脆弱,增加了发展神经精神障碍的风险。总之,GSK3β 依赖性调节电压门控离子通道可能是神经治疗开发的重要药理学靶标。